World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 1 June 2015
Main ID:  NCT02085902
Date of registration: 07/03/2014
Prospective Registration: No
Primary sponsor: Centre Hospitalier Departemental Vendee
Public title: Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery? VesiRop
Scientific title: Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?
Date of first enrolment: March 2014
Target sample size: 120
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02085902
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)  
Phase:  Phase 4
Countries of recruitment
France
Contacts
Name:     Emeric ABET, Dr
Address: 
Telephone:
Email:
Affiliation:  CHD Vendée La Roche sur Yon
Key inclusion & exclusion criteria

Inclusion Criteria:

- Programmed Cholecystectomy

- Laparoscopy

- Man and woman

- = 18

- ASA 1 or 2

- Not living alone

- Patient receiving social security coverage

- Signature of Informed Consent Form

Exclusion Criteria:

- Cholecystectomy emergency

- Patient minor

- Pregnant woman (pregnancy test) or during breastfeeding

- Conversion to laparotomy

- Patient anticoagulant curative dose

- Living alone

- Patient addict

- Peptic Ulcer

- Refusal to enter the protocol

- Chronic requiring analgesics long-term

- Immunosuppression

- Long-term Treatment with corticosteroids

- Discovery intraoperative calculation in the bile duct

- Contraindication to ropivacaine (see cons-indications to ropivacaine)

- Hypersensitivity to study treatment or concomitant medications anesthesia

- Cardiac or unbalanced epileptic patients (due to the risk of cardiovascular and
neurological local anesthetics)

- Patients ASA = 3

- Patient <50 kg



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Cholecystectomy
Laparoscopy
Intervention(s)
Drug: Ropivacaine
Primary Outcome(s)
Time to discharge patient after surgery [Time Frame: 6 hours postoperative]
Secondary Outcome(s)
Secondary ID(s)
CHD 079-13
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history